TABLE 1.

Pathway enrichment of the METH group.

Pathway enrichment
No	Pathway ID	Pathway	Count	%	p-value
1	rno04151	Metabolic pathways	54	0.070,537,522	0.001,386,404
2	rno00190	Oxidative phosphorylation	12	0.015,675,005	0.002,143,915
3	rno00510	N-Glycan biosynthesis	7	0.009,143,753	0.002,439,666
4	rno05012	Parkinson’s disease	12	0.015,675,005	0.003,272,982
5	rno01130	Biosynthesis of antibiotics	14	0.018,287,506	0.00778,871
6	rno03050	Proteasome	6	0.007,837,502	0.009,337,467
7	rno05010	Alzheimer’s disease	12	0.015,675,005	0.012,312,085
8	rno04152	AMPK signaling pathway	9	0.011,756,254	0.025,718,304
9	rno04540	Gap junction	7	0.009,143,753	0.035,091,577
10	rno04115	p53 signaling pathway	6	0.007,837,502	0.044,351,924
11	rno05206	MicroRNAs in cancer	9	0.011,756,254	0.045,162,063